Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0Magnetic Resonance in Medicine

Using Manganese‐Enhanced DCE‐MRI to Assess Blood‐Cerebrospinal Fluid Barrier Transport

  1. 1UCL Centre for Advanced Biomedical Imaging, Division of Medicine University College London London UK

Abstract

Purpose: We developed a dynamic, heavily T2‐weighted (hT2w) FLAIR protocol to resolve acute Mn2+ transport kinetics, as a proxy for Ca2+, across the choroid plexus (ChP)—cerebrospinal fluid (CSF) interface, in vivo. By quantifying intercompartmental Mn2+ dynamics, and comparing these with Gd‐DOTA, we sought to characterize blood‐CSF‐barrier (BCSFB)‐mediated tracer transport, combining high in‐plane resolution and 4‐min temporal sampling.

Methods: hT2w‐FLAIR DCE MRI was conducted in anesthetized C57BL/6 mice, receiving intravenous Mn2+ or Gd‐DOTA. Semi‐quantitative tracer kinetic modeling permitted regional and inter‐tracer comparisons.

Results: Mn2+ rapidly crossed from the vasculature into the CSF, across the ChP, with similar arrival times and time‐to‐peak across compartments. Mn2+ delivery into the ChP exhibited a 5.7‐fold steeper uptake rate (p = 0.031) and a 5.6‐fold higher peak signal amplitude (p = 0.0028) than in the LV‐CSF. In contrast, Gd‐DOTA exhibited a 2.2‐fold shorter ChP plateau duration (p = 0.034) and 2.2‐fold faster ChP clearance rate (p = 0.0047), compared to Mn2+. Within the CSF, there were significant temporal delays with Gd‐DOTA relative to Mn2+: a lengthened arrival (eight‐fold, p = 0.045) and time‐to‐peak (six‐fold, p = 0.024).

Conclusion: Our hT2w‐FLAIR DCE‐MRI approach captured the early BCSFB transport window for Mn2+, providing distinct ChP and LV‐CSF kinetics at a higher temporal resolution and with reduced CSF signal contamination compared to prior approaches. These findings highlight that MRI tracer choice strongly shapes measured BCSFB kinetics, and supports the use of Mn2+ as a tool for probing compartment‐specific ChP transport.

Related

  1. Simulating Transport Across the Blood-Brain Barrier Endothelial Membrane: Comparing Unbiased Molecular Dynamics Methods to Enhanced Sampling Protocols.
    Jerry Oluwasegun, Ben William Franey, Christian Jorgensen
    MembranesPeer-reviewedCC BYFull textNeurologyEurope PMC
  2. Manganese Transport and Sediment Remobilization in a Tidal Estuary: Parameter Sensitivity and Uncertainty Analysis
    Hong-Ming Liu, Wen-Cheng Liu, Wei-Che Huang +1
    ToxicsPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  3. Cerebrospinal fluid MMP-2 and TIMP-2 reflect blood–cerebrospinal fluid barrier dysfunction in Guillain–Barré syndrome and CIDP
    Jiuheng Zhong, Jia Li, Ziqi Mo +7
    Frontiers in NeurologyPeer-reviewedCC BY 4.0Full textNeurologyCrossrefEurope PMCPMCEurope PMC
  4. Transient HBV entry into cerebrospinal fluid following blood-brain barrier disruption: a case of HSV-2 encephalitis with polymicrobial detection elucidated by serial targeted next-generation sequencing
    Xuejun Leng, Yongku Li, Lijuan Gao +2
    BMC Infectious DiseasesPeer-reviewedCC BY-NC-ND 4.0Full textInfectious diseasePMC
  5. Functional brain imaging and targeted lesion studies using manganese-enhanced MRI and focused ultrasound in non-conventional model species
    Pierre Estienne, Gwenaël Pagé, Théo Durier +3
    Journal of Neuroscience MethodsPeer-reviewedCC BY 4.0Full text1 citedNeuroscienceSystems & synthetic biologyHAL
BibTeX
@article{perera2026using,
  title = {{Using Manganese‐Enhanced DCE‐MRI to Assess Blood‐Cerebrospinal Fluid Barrier Transport}},
  author = {Charith Perera and Zhiping Feng and Shereen Nizari and Phillip Muza and Christina Katsiva and Tammy L. Kalber and Mark F. Lythgoe and Ian F. Harrison and Daniel J. Stuckey and Jack A. Wells},
  journal = {Magnetic Resonance in Medicine},
  year = {2026},
  month = jul,
  doi = {10.1002/mrm.70531},
  url = {https://doi.org/10.1002/mrm.70531},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Using Manganese‐Enhanced DCE‐MRI to Assess Blood‐Cerebrospinal Fluid Barrier Transport
AU  - Charith Perera
AU  - Zhiping Feng
AU  - Shereen Nizari
AU  - Phillip Muza
AU  - Christina Katsiva
AU  - Tammy L. Kalber
AU  - Mark F. Lythgoe
AU  - Ian F. Harrison
AU  - Daniel J. Stuckey
AU  - Jack A. Wells
PY  - 2026
DA  - 2026/07/26
JO  - Magnetic Resonance in Medicine
DO  - 10.1002/mrm.70531
UR  - https://doi.org/10.1002/mrm.70531
AB  - Purpose: We developed a dynamic, heavily T2‐weighted (hT2w) FLAIR protocol to resolve acute Mn2+ transport kinetics, as a proxy for Ca2+, across the choroid plexus (ChP)—cerebrospinal fluid (CSF) interface, in vivo. By quantifying intercompartmental Mn2+ dynamics, and comparing these with Gd‐DOTA, we sought to characterize blood‐CSF‐barrier (BCSFB)‐mediated tracer transport, combining high in‐plane resolution and 4‐min temporal sampling.  Methods: hT2w‐FLAIR DCE MRI was conducted in anesthetized C57BL/6 mice, receiving intravenous Mn2+ or Gd‐DOTA. Semi‐quantitative tracer kinetic modeling permitted regional and inter‐tracer comparisons.  Results: Mn2+ rapidly crossed from the vasculature into the CSF, across the ChP, with similar arrival times and time‐to‐peak across compartments. Mn2+ delivery into the ChP exhibited a 5.7‐fold steeper uptake rate (p = 0.031) and a 5.6‐fold higher peak signal amplitude (p = 0.0028) than in the LV‐CSF. In contrast, Gd‐DOTA exhibited a 2.2‐fold shorter ChP plateau duration (p = 0.034) and 2.2‐fold faster ChP clearance rate (p = 0.0047), compared to Mn2+. Within the CSF, there were significant temporal delays with Gd‐DOTA relative to Mn2+: a lengthened arrival (eight‐fold, p = 0.045) and time‐to‐peak (six‐fold, p = 0.024).  Conclusion: Our hT2w‐FLAIR DCE‐MRI approach captured the early BCSFB transport window for Mn2+, providing distinct ChP and LV‐CSF kinetics at a higher temporal resolution and with reduced CSF signal contamination compared to prior approaches. These findings highlight that MRI tracer choice strongly shapes measured BCSFB kinetics, and supports the use of Mn2+ as a tool for probing compartment‐specific ChP transport.
SN  - 0740-3194
SN  - 1522-2594
ER  -